Dexterdelta Pharma Private Limited - Company Profile

It is a pharma private limited company based in Nashik, Maharashtra, India, established in 2022.
2022 Nashik, Maharashtra, India Struck Off
Last Updated:
Access Report
About Dexterdelta Pharma Private Limited

Dexterdelta Pharma Private Limited, a struck off private limited company, was established on 19 January 2022 in Nashik, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2022PTC375124. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Deepak Kalyanji Chande (Director), Sandip Jagannath Patil (Director), Shubh Deepak Chande (Director). It is based at Plot No. 4, Sr No. 613/3/5 Near Kalika Mandir, Behind Surbhi Hotel, Nashik, Maharashtra, 422001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2022PTC375124

  • Registration Number

    375124

  • Incorporation Date

    19 January 2022

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 1 Month
Company report

Dexterdelta Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dexterdelta Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dexterdelta Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Deepak Kalyanji Chande Director 19 Jan 2022 Current
Sandip Jagannath Patil Director 19 Jan 2022 Current
Shubh Deepak Chande Director 19 Jan 2022 Current
Pravin Suresh Yeole Director 19 Jan 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dexterdelta Pharma.

Enhance accessibility to Dexterdelta Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Dexterdelta Pharma revenue growth over time
Dexterdelta Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dexterdelta Pharma?

Unlock access to Dexterdelta Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dexterdelta Pharma?

Dexterdelta Pharma has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dexterdelta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dexterdelta Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dexterdelta Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Deepak Kalyanji Chande was appointed as a Director was appointed as a Director on 19 Jan 2022 & has been associated with this company since 4 years 1 month . was completed.

  • Director Appointment

    The activity Sandip Jagannath Patil was appointed as a Director was appointed as a Director on 19 Jan 2022 & has been associated with this company since 4 years 1 month . was completed.

  • Director Appointment

    Shubh Deepak Chande was appointed as a Director was appointed as a Director on 19 Jan 2022 & has been associated with this company since 4 years 1 month . was recorded as a recent event.

  • Director Appointment

    Pravin Suresh Yeole was appointed as a Director was appointed as a Director on 19 Jan 2022 & has been associated with this company since 4 years 1 month . was recorded as a recent event.

  • Company Incorporation

    Progress on Dexterdelta Pharma Private Limited was registered on 19 Jan 2022 with Roc Mumbai & aged 4 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dexterdelta Pharma Private Limited?

The CIN of Dexterdelta Pharma Private Limited is U24230MH2022PTC375124.

Where is Dexterdelta Pharma Private Limited headquartered?

Dexterdelta Pharma Private Limited is headquartered at Plot No. 4, Sr No. 613/3/5 Near Kalika Mandir, Behind Surbhi Hotel, Nashik, Maharashtra, 422001.

When was Dexterdelta Pharma Private Limited incorporated?

Dexterdelta Pharma Private Limited was incorporated on 19 January 2022.

Who are the current directors of Dexterdelta Pharma Private Limited?

The current directors of Dexterdelta Pharma Private Limited are

What is the primary industry of Dexterdelta Pharma Private Limited?

The primary industry of Dexterdelta Pharma Private Limited is Pharma.

Is Dexterdelta Pharma Private Limited a listed company?

Dexterdelta Pharma Private Limited is unlisted.

What is the capital structure of Dexterdelta Pharma Private Limited?

The authorized capital of Dexterdelta Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available